Please assess the completion status of the following clinical trial:

Trial Title: Study of Colchicine to Prevent the Postpericardiotomy Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients in the third day after a cardiac surgery operation~* Age≥ 18 years~* Informed consent~Exclusion Criteria:~All evaluated before the surgical operation:~* Known severe liver disease and/or elevated transaminases \>1.5 times the upper limit of normality~* Serum creatinine \>2.5 mg/dl~* Serum creatine kinase (CK) over the upper limit of normality or known myopathy~* Known gastrointestinal or blood disease~* Pregnant or lactating women or women not protected by a contraception method~* Known hypersensibility to colchicine~* Treatment with colchicine at enrolment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).